Breast Cancer (Locally Advanced or Metastatic), Colorectal Cancer, Lymphoma
Conditions
Brief summary
The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment. The main question\[s\] it aims to answer are: Is ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patients (meaning do patients like it)? Researchers will compare the ASSIST phone application to see how it compares to usual clinical care. Participants on the ASSIST arm will use the ASSIST phone application for 12 weeks, and participants in both groups will complete surveys.
Interventions
OTHERASSIST phone application
The intervention consists of a smartphone-based application that provides personalized support using AI during cancer treatment. Patients will also receive standard care from their oncology team, including routine symptom management and supportive care measures.
Sponsors
Patrick C. Johnson, MD
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age 18 years or older 2. Ability to understand English 3. About to begin definitive systemic treatment (or within 4 weeks of beginning treatment) based upon the oncology treatment intent form for a new diagnosis of breast cancer, colorectal cancer, or lymphoma. 4. Expected treatment duration of at least 12 weeks 5. Own or willing to receive a smartphone
Exclusion criteria
1. Cognitive impairment that would interfere with ability to use smartphone application (as assessed by their attending physician) 2. Visual or motor impairment that would prevent smartphone use 3. Expected survival less than 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recruitment Rates | From enrollment to end of intervention at 12 weeks | We will deem the intervention feasible if recruitment rates achieve ≥ 60% of eligible patients |
| Percentage of participants using the digital application once per week in at least 7/12 weeks | From enrollment to end of intervention at 12 weeks | The intervention will be feasible if among those enrolled and randomized to the intervention arm, ≥ 60% use ASSIST once per week in at least 7/12 weeks. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Acceptability | From enrollment to the end of the intervention at 12 weeks | The intervention will be deemed acceptable if ≥ 80% of patients on the ASSIST intervention arm report satisfaction based on a rating of "Somewhat satisfied" or "Very satisfied" when asked about their experience with the intervention. |
Countries
United States
Contacts
CONTACTPatrick C Johnson, MD
Outcome results
None listed